The Effect of Urtica dioica L. On Glucose and Lipid Indexes in Diabetic Patients

The studdy effect of aquitic extract of Urtica dioica L. on Glycemic and and Lipidmic indexes in diabetic Patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015010720594N1

Enrollment

108

Registered

2016-04-14

Start date

2014-03-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic mellitus type2. Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: The study of aqueous extract of nettle as a herbal medicine for three months is available to patients?So that three meals daily in divided 1 ml of the extract, half an hour before meal

Treatment - Drugs

Placebo

The study of aqueous extract of nettle as a herbal medicine for three months is available to patients?So that three meals daily in divided 1 ml of the extract, half an hour before meals ,Within a mont

Placebo intervention: natural lemon juice Dosage: daily divided in three doses of 1 cc How to use the drug: half an hour before meals eaten Course of medication intervention: Three months to the to

Eligibility

Sex/Gender

All

Age

34 Years to 79 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : age over 30 years; HbA1c less than 10 %; the most common diabetes medications ( Metformin ?Glibenclamide ) Exclusion criteria : a history of cardiovascular disease; renal disease; infectious disease; liver disease; thyroid disease; allergies disease; angina disease; consumption of nonsteroidal antiinflammatory drugs (NSAIDs); consumption of warfarin; consumption of estrogen and progesterone drugs; smoking, consumption of dietary supplements; consumption of herbal decoction; pregnancy and lactation

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
HbA1c. Timepoint: After three month. Method of measurement: Blood Sampling.;HDL. Timepoint: After three month. Method of measurement: Blood Sampling.;LDL. Timepoint: After three month. Method of measurement: Blood sampling.;TG. Timepoint: After three month. Method of measurement: Blood Sampling.;FBS. Timepoint: After three month. Method of measurement: Blood Sampling.;BS2pp. Timepoint: after three month. Method of measurement: blood sampling.;Cholesterol. Timepoint: After three month. Method of measurement: Blood Sampling.	—

Measure

Time frame

HbA1c. Timepoint: After three month. Method of measurement: Blood Sampling.;HDL. Timepoint: After three month. Method of measurement: Blood Sampling.;LDL. Timepoint: After three month. Method of measurement: Blood sampling.;TG. Timepoint: After three month. Method of measurement: Blood Sampling.;FBS. Timepoint: After three month. Method of measurement: Blood Sampling.;BS2pp. Timepoint: after three month. Method of measurement: blood sampling.;Cholesterol. Timepoint: After three month. Method of measurement: Blood Sampling.

—

Secondary

Measure	Time frame
Body mass index. Timepoint: The baseline. Method of measurement: Meter?Balance.;Systolic Blood Pressur. Timepoint: first and last Undertaking Study. Method of measurement: Barometer.;Dyastolic Blood Pressure. Timepoint: First and last Undertaking Study. Method of measurement: Barometer.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDR. Sepide Nazemi

Imam Hussein Shahrood Hospital Medical Center

Nazemi1393@shu.ac.ir+233 2343000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026